End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
314,000 KRW | -1.41% | -0.95% | -10.92% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
05-01 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.92% | 2.95B | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.
- Hanmi Pharma to Manufacture COVID-19 Vaccine Developed by India's Zydus Cadila